You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 91 No. 4, APRIL 1953 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

SERUM MUCOPROTEIN LEVEL IN DIFFERENTIATION OF HEPATOGENIC FROM OBSTRUCTIVE JAUNDICE

EZRA M. GREENSPAN, M.D.; DAVID A. DREILING, M.D.

AMA Arch Intern Med. 1953;91(4):474-486.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

DIFFERENTIATION of hepatogenic from obstructive jaundice continues to be a common diagnostic problem, despite the ever-expanding "battery" of liver function tests now available to the clinician. Such frequently employed tests as cephalin flocculation, thymol turbidity, zinc sulfate flocculation, and alkaline phosphatase activity depend upon relative or absolute changes in serum albumin, beta globulin, or gamma globulin or upon impairment of biliary excretion. Although increase of certain serum carbohydrate components related to the alpha-globulin fractions has long been recognized to occur in the presence of inflammatory and neoplastic disease,1 no attempt has been made until recently to employ measurement of these components in diagnosis of hepatic or biliary tract disease. In an extension of biochemical studies on the effect of chemotherapeutic agents in patients with advanced neoplastic disease, one of us (E. M. G.) and his colleagues2 reported that the level of serum mucoprotein, an alpha-globulin constituent, appeared to . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the National Cancer Institute, National Institutes of Health, United States Public Health Service (Federal Security Agency), Bethesda, Md., and the Medical and Surgical Services of Mount Sinai Hospital, New York.


Footnotes

Bernice Gitler gave technical assistance in this study.

This work was initiated at the Clinical Research unit of the National Cancer Institute, United States Public Health Service Hospital, Baltimore.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1953 American Medical Association. All Rights Reserved.